Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Oct, 13 2025
Nov, 14 2025
Feb, 25 2026
May, 9 2024
Mar, 4 2026